Status:
COMPLETED
RS-3000 Lite Agreement Study
Lead Sponsor:
Nidek Co. LTD.
Conditions:
Healthy
Eligibility:
All Genders
20+ years
Brief Summary
The primary objectives of the study are to assess the agreement between the two different scan mode of the RS-3000 Lite.
Eligibility Criteria
Inclusion
- Subjects who do not have pathology in both eyes
Exclusion
- Subjects who have any of the following conditions:
- Diabetes mellitus (DM) and/or diabetic retinopathy
- Uncontrolled Hypertension (HT)
- Cerebral infarction, cerebral hemorrhage, cranial nerve neoplasm and other central nervous system diseases affecting vision
- Cardiac, hepatic, renal and hematologic diseases
- A current condition requiring systemic administration of steroid
- A history of, or currently receiving, anticancer therapy
- Epileptic seizures which are optically induced
- Dementia
- Note: Additional criteria may apply
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02198560
Start Date
August 1 2014
Last Update
September 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nabeta Ganaka Iin
Okazaki, Aichi-ken, Japan, 4440226